The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.


Journal

Virology
ISSN: 1096-0341
Titre abrégé: Virology
Pays: United States
ID NLM: 0110674

Informations de publication

Date de publication:
05 2019
Historique:
received: 05 11 2018
revised: 25 03 2019
accepted: 26 03 2019
pubmed: 9 4 2019
medline: 23 10 2019
entrez: 9 4 2019
Statut: ppublish

Résumé

SAMHD1 is a human restriction factor known to prevent infection of macrophages, resting CD4

Identifiants

pubmed: 30959264
pii: S0042-6822(19)30089-3
doi: 10.1016/j.virol.2019.03.018
pmc: PMC6487861
mid: NIHMS1025003
pii:
doi:

Substances chimiques

MX2 protein, human 0
Myxovirus Resistance Proteins 0
SAM Domain and HD Domain-Containing Protein 1 EC 3.1.5.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

260-268

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI150455
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI087390
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007501
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM123540
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150451
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Références

J Virol. 2008 Jul;82(13):6557-65
pubmed: 18417568
Nat Immunol. 2010 Nov;11(11):1005-13
pubmed: 20871604
Blood. 2011 Jul 14;118(2):298-308
pubmed: 21411754
Nat Genet. 2009 Jul;41(7):829-32
pubmed: 19525956
J Virol. 2016 Jul 11;90(15):6918-6935
pubmed: 27307565
Cell Host Microbe. 2013 Apr 17;13(4):441-51
pubmed: 23601106
Proc Natl Acad Sci U S A. 2014 May 6;111(18):E1843-51
pubmed: 24753578
Nature. 2013 Oct 24;502(7472):559-62
pubmed: 24048477
Retrovirology. 2007 Jan 09;4:2
pubmed: 17212817
J Immunol. 2014 Aug 15;193(4):1988-97
pubmed: 25015816
J Virol. 2017 Jul 12;91(15):
pubmed: 28490595
J Virol. 2015 Dec 30;90(6):3056-64
pubmed: 26719253
J Virol. 2015 Mar;89(6):3285-94
pubmed: 25568212
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4305-14
pubmed: 25267621
J Biol Chem. 2016 Oct 7;291(41):21407-21413
pubmed: 27566548
Nat Rev Mol Cell Biol. 2016 Jan;17(1):5-15
pubmed: 26670017
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8957-62
pubmed: 15184662
J Virol. 2015 Apr;89(7):4030-4
pubmed: 25609804
Retrovirology. 2014 Apr 08;11:29
pubmed: 24712655
J Biol Chem. 1996 Sep 20;271(38):23478-86
pubmed: 8798556
J Virol. 1991 Nov;65(11):6362-4
pubmed: 1920639
Science. 1999 Jan 1;283(5398):80-3
pubmed: 9872746
Science. 2013 Aug 23;341(6148):903-6
pubmed: 23929945
Sci Rep. 2016 Aug 11;6:31353
pubmed: 27511536
PLoS Pathog. 2011 Dec;7(12):e1002425
pubmed: 22174685
Retrovirology. 2012 Oct 23;9:87
pubmed: 23092122
Cell Rep. 2013 Apr 25;3(4):1036-43
pubmed: 23602554
Virology. 2008 Sep 1;378(2):233-42
pubmed: 18586294
Mol Immunol. 2018 Sep;101:450-460
pubmed: 30099227
Retrovirology. 2014 Aug 14;11:68
pubmed: 25123063
J Immunol. 1990 Oct 15;145(8):2669-76
pubmed: 1976701
J Virol. 2014 Aug;88(16):9017-26
pubmed: 24899177
J Biol Chem. 2012 Jun 22;287(26):21570-4
pubmed: 22589553
Retrovirology. 2014 Feb 01;11:12
pubmed: 24485168
J Virol. 2008 Dec;82(24):12335-45
pubmed: 18829761
J Biol Chem. 2015 Oct 30;290(44):26352-9
pubmed: 26294762
Nat Med. 2012 Nov;18(11):1682-7
pubmed: 22972397
J Virol. 2014 Jul;88(14):7738-52
pubmed: 24760893
J Virol. 2014 May;88(10):5834-44
pubmed: 24623419
Nature. 2013 Nov 21;503(7476):402-405
pubmed: 24196705
J Biol Chem. 2011 Dec 23;286(51):43596-600
pubmed: 22069334
Nature. 2011 May 25;474(7353):654-7
pubmed: 21613998
Retrovirology. 2013 Nov 12;10:131
pubmed: 24219908
PLoS Pathog. 2015 Oct 02;11(10):e1005194
pubmed: 26431200
Nature. 2013 Oct 24;502(7472):563-6
pubmed: 24121441
J Virol. 2003 Sep;77(17):9295-304
pubmed: 12915545
Nat Immunol. 2012 Feb 12;13(3):223-228
pubmed: 22327569
J Biol Chem. 2015 May 22;290(21):13279-92
pubmed: 25847232
J Virol. 2013 Nov;87(21):11516-24
pubmed: 23966382
Cell Host Microbe. 2014 Nov 12;16(5):627-638
pubmed: 25312384
J Virol. 2015 Aug;89(16):8599-610
pubmed: 26063425
J Virol. 2012 Dec;86(23):12552-60
pubmed: 22973040
Methods Mol Biol. 2014;1087:29-36
pubmed: 24158811
J Virol. 2011 Sep;85(17):8725-37
pubmed: 21734049
Cell Host Microbe. 2013 Oct 16;14(4):398-410
pubmed: 24055605
Nature. 2011 Jun 29;474(7353):658-61
pubmed: 21720370
Nature. 2011 Nov 06;480(7377):379-82
pubmed: 22056990
Retrovirology. 2014 Oct 25;11:90
pubmed: 25348155
Retrovirology. 2012 Jun 12;9:49
pubmed: 22691373

Auteurs

Cindy Buffone (C)

Albert Einstein College of Medicine, Microbiology and Immunology, Bronx, NY, 10461, USA.

Juliane Kutzner (J)

University Hospital Heidelberg, Department of Infectious Diseases, Heidelberg, 69120, Germany.

Silvana Opp (S)

Albert Einstein College of Medicine, Microbiology and Immunology, Bronx, NY, 10461, USA.

Alicia Martinez-Lopez (A)

Albert Einstein College of Medicine, Microbiology and Immunology, Bronx, NY, 10461, USA.

Anastasia Selyutina (A)

Albert Einstein College of Medicine, Microbiology and Immunology, Bronx, NY, 10461, USA.

Si Ana Coggings (SA)

Emory University, Pediatrics, Atlanta, 30322, Georgia.

Lydia R Studdard (LR)

Emory University, Pediatrics, Atlanta, 30322, Georgia.

Lingmei Ding (L)

Cincinnati Children's Hospital, Infectious Diseases, Cincinnati, OH, 45229, USA.

Baek Kim (B)

Emory University, Pediatrics, Atlanta, 30322, Georgia.

Paul Spearman (P)

Cincinnati Children's Hospital, Infectious Diseases, Cincinnati, OH, 45229, USA.

Torsten Schaller (T)

University Hospital Heidelberg, Department of Infectious Diseases, Heidelberg, 69120, Germany.

Felipe Diaz-Griffero (F)

Albert Einstein College of Medicine, Microbiology and Immunology, Bronx, NY, 10461, USA. Electronic address: felipe.diaz-griffero@einstein.yu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH